Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve

Research output: Contribution to journalArticlepeer-review

Abstract

Construction of Bifidobacterium breve capable of production of secreted biologically active human interleukin-10 (hIL-10) is described. ORF coding for full-length mature human interleukin-10 was cloned into a series of expression vectors. This resulted in generation of translational fusions between hIL-10 and signal peptides sequences derived from Bifidobacterium breve genes sec2, apuB and B. adolescentis gene amyB under the control of constitutively active bifidobacterial promoter. We have shown that fusion to amyB signal peptide resulted in highest expression level of hIL-10 at the mRNA and protein level. Secreted hIL-10 was highly unstable in bifidobacterial culture supernatants in standard growth conditions. However, incubation of stationary cultures in buffered tissue culture medium resulted in production of stable biologically active hIL-10, albeit in low amounts (1.9 ng/ml).

Original languageEnglish
Pages (from-to)769-774
Number of pages6
JournalArchives of Microbiology
Volume192
Issue number9
DOIs
Publication statusPublished - Sep 2010
Externally publishedYes

Keywords

  • Bifidobacterium
  • Inflammatory bowel disease
  • Interleukin-10
  • Vector

Fingerprint

Dive into the research topics of 'Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve'. Together they form a unique fingerprint.

Cite this